Atlantic Union Bankshares Corp Abb Vie Inc. Transaction History

Atlantic Union Bankshares Corp

$1.62 Billion
Q3 2024

A detailed history of Atlantic Union Bankshares Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 95,112 shares of ABBV stock, worth $17.1 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

95,112

Previous 95,298 0.2%

Holding current value

$17.1 Million

Previous $16.3 Million 14.91%

% of portfolio

1.16%

Previous 1.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $30,474 - $37,075	-186 Reduced 0.2%	95,112 $18.8 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $9.69 Million - $11.3 Million	62,569 Added 191.17%	95,298 $16.3 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $70,160 - $79,941	-439 Reduced 1.32%	32,729 $5.96 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $197,731 - $222,691	-1,437 Reduced 4.15%	33,168 $5.14 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $53,970 - $62,478	-404 Reduced 1.15%	34,605 $5.16 Million
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $347,838 - $432,862	-2,625 Reduced 6.98%	35,009 $4.72 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $269,263 - $310,097	-1,862 Reduced 4.71%	37,634 $6 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $430,144 - $515,855	-3,110 Reduced 7.3%	39,496 $6.39 Million
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $693,463 - $795,356	-5,167 Reduced 10.82%	42,606 $5.72 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $98,811 - $125,621	-718 Reduced 1.48%	47,773 $7.32 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $2.19 Million - $2.72 Million	-16,583 Reduced 25.48%	48,491 $7.86 Million
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $215,182 - $272,267	-2,003 Reduced 2.99%	65,074 $8.81 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $89,588 - $101,696	-842 Reduced 1.24%	67,077 $7.24 Million
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $88,481 - $98,573	-841 Reduced 1.22%	67,919 $7.65 Million
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $152,324 - $167,691	-1,489 Reduced 2.12%	68,760 $7.44 Million
Q4 2020 Feb 01, 2021	SELL	$80.49 - $108.67 $225,452 - $304,384	-2,801 Reduced 3.83%	70,249 $7.53 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $106,098 - $124,525	-1,235 Reduced 1.66%	73,050 $6.4 Million
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $298,249 - $399,101	4,065 Added 5.79%	74,285 $7.29 Million
Q1 2020 Apr 10, 2020	SELL	$64.5 - $97.79 $264,063 - $400,352	-4,094 Reduced 5.51%	70,220 $5.35 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $177,223 - $221,744	2,457 Added 3.42%	74,314 $6.58 Million
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $456,227 - $548,515	-7,244 Reduced 9.16%	71,857 $5.44 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $4.26 Million - $5.44 Million	64,797 Added 453.0%	79,101 $5.75 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $2,699 - $3,177	35 Added 0.25%	14,304 $1.15 Million
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $7,395 - $9,120	-95 Reduced 0.66%	14,269 $1.32 Million
Q3 2018 Oct 11, 2018	SELL	$88.91 - $98.84 $81,263 - $90,339	-914 Reduced 5.98%	14,364 $1.36 Million
Q2 2018 Jul 12, 2018	SELL	$89.78 - $106.23 $31,782 - $37,605	-354 Reduced 2.26%	15,278 $1.42 Million
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $2,944 - $3,942	-32 Reduced 0.2%	15,632 $1.48 Million
Q4 2017 Jan 10, 2018	BUY	$89.56 - $98.21 $8,956 - $9,821	100 Added 0.64%	15,664 $1.52 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $1.09 Million - $1.39 Million	15,564	15,564 $1.38 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.

Account

Atlantic Union Bankshares Corp Abb Vie Inc. Transaction History